| Absorption |
| Blood-Brain Barrier | BBB+ | 0.6556 |
| Human Intestinal Absorption | HIA+ | 0.9959 |
| Caco-2 Permeability | Caco2+ | 0.8412 |
| P-glycoprotein Substrate | Substrate | 0.7237 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8004 |
| Non-inhibitor | 0.8340 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7467 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8153 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7967 |
| CYP450 2D6 Substrate | Substrate | 0.8770 |
| CYP450 3A4 Substrate | Non-substrate | 0.6474 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6390 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8298 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.7052 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7971 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.6076 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5795 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9435 |
| Inhibitor | 0.7179 |
| AMES Toxicity | Non AMES toxic | 0.9133 |
| Carcinogens | Non-carcinogens | 0.9337 |
| Fish Toxicity | High FHMT | 0.9525 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9363 |
| Honey Bee Toxicity | Low HBT | 0.5331 |
| Biodegradation | Not ready biodegradable | 0.9958 |
| Acute Oral Toxicity | II | 0.6422 |
| Carcinogenicity (Three-class) | Non-required | 0.6005 |